Subhas C. Ganguli

598 total citations
18 papers, 490 citations indexed

About

Subhas C. Ganguli is a scholar working on Gastroenterology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Subhas C. Ganguli has authored 18 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Gastroenterology, 5 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Subhas C. Ganguli's work include Gastrointestinal motility and disorders (6 papers), Receptor Mechanisms and Signaling (5 papers) and Neuropeptides and Animal Physiology (5 papers). Subhas C. Ganguli is often cited by papers focused on Gastrointestinal motility and disorders (6 papers), Receptor Mechanisms and Signaling (5 papers) and Neuropeptides and Animal Physiology (5 papers). Subhas C. Ganguli collaborates with scholars based in Canada, United States and Netherlands. Subhas C. Ganguli's co-authors include Elizabeth M. Hadac, Laurence J. Miller, Martin Holtmann, Stephen M. Collins, Markad V. Kamath, E. Jan Irvine, Terry Kenakin, Maoqing Dong, Yan W. Asmann and Pierre Paré and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Hepatology.

In The Last Decade

Subhas C. Ganguli

18 papers receiving 477 citations

Peers

Countries citing papers authored by Subhas C. Ganguli

Since Specialization

Citations

This map shows the geographic impact of Subhas C. Ganguli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subhas C. Ganguli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subhas C. Ganguli more than expected).

Fields of papers citing papers by Subhas C. Ganguli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Subhas C. Ganguli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subhas C. Ganguli. The network helps show where Subhas C. Ganguli may publish in the future.

Co-authorship network of co-authors of Subhas C. Ganguli

This figure shows the co-authorship network connecting the top 25 collaborators of Subhas C. Ganguli. A scholar is included among the top collaborators of Subhas C. Ganguli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Subhas C. Ganguli. Subhas C. Ganguli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Implementation of a Whole Food Plant Based Diet in a Food as Prevention Program in a Resource Constrained Environment 2022 ·PubMed ·Subhas C. Ganguli, (unknown), Keith Tsoi	2
2	The Benefit of Fentanyl in Effective Sedation and Quality of Upper Endoscopy: A Double-Blinded Randomized Trial of Fentanyl Added to Midazolam Versus Midazolam Alone for Sedation 2018 ·Journal of the Canadian Association of Gastroenterology ·Khurram J Khan, (unknown), Subhas C. Ganguli, (unknown), (unknown), Keith Tsoi, David Morgan	8
3	Retroperitoneal liposarcoma in an adult patient with Down syndrome. 2011 ·PubMed ·(unknown), Karen D'Silva, Subhas C. Ganguli, (unknown), Franco DeNardi	2
4	Heightened central affective response to visceral sensations of pain and discomfort in IBS 2010 ·Neurogastroenterology & Motility ·Geoffrey B. Hall, Markad V. Kamath, Stephen M. Collins, Subhas C. Ganguli, (unknown), (unknown), Alfred Bayati, J. Bienenstock	52
5	377 A Randomized, Double-Blind, Placebo-Controlled Trial with a Novel Dual Noradrenergic Reuptake Inhibitor (NARI) and 5-HT3 Antagonist: Results of a Phase II 8-Week Study in Female Patients with Diarrhea Predominant Irritable Bowel Syndrome (D-IBS) 2008 ·Gastroenterology ·William G. Paterson, J. Springer, Michael O’Mahony, R. P. E. Reynolds, Subhas C. Ganguli, Brian Feagan, (unknown), Steven B. Landau	4
6	T1397 A Novel, Oral 5HT3 Partial Agonist, DDP733, Improves Overall Response in Patients with Irritable Bowel Syndrome and Constipation (IBS-c): A Randomized, Double Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study 2008 ·Gastroenterology ·William G. Paterson, (unknown), Subhas C. Ganguli, R. P. E. Reynolds, (unknown), Michael O’Mahony, Pierre Paré, (unknown), Brian Feagan, Steven B. Landau	7
7	A comparison of autonomic function in patients with inflammatory bowel disease and in healthy controls 2007 ·Neurogastroenterology & Motility ·Subhas C. Ganguli, Markad V. Kamath, (unknown), (unknown), E. Jan Irvine, Stephen M. Collins, Gervais Tougas	47
8	Recommendations on Chronic Constipation (including Constipation Associated with Irritable Bowel Syndrome) Treatment 2007 ·Canadian Journal of Gastroenterology ·Pierre Paré, Ronald Bridges, M C Champion, Subhas C. Ganguli, James R. Gray, (unknown), Victor Plourde, Pierre Poitras, Geoffrey K. Turnbull, Paul Moayyedi, Nigel Flook, Stephen M. Collins	17
9	Recommendations on Chronic Constipation (Including Constipation Associated with Irritable Bowel Syndrome) Treatment 2007 ·Canadian Journal of Gastroenterology and Hepatology ·Pierre Paré, Ronald Bridges, M C Champion, Subhas C. Ganguli, James R. Gray, E. Jan Irvine, Victor Plourde, Pierre Poitras, Geoffrey K. Turnbull, Paul Moayyedi, Nigel Flook, Stephen M. Collins	60
10	Alternative Medicine Use by Canadian Ambulatory Gastroenterology Patients: Secular Trend or Epidemic? 2004 ·The American Journal of Gastroenterology ·Subhas C. Ganguli, (unknown), (unknown)	45
11	Use and misuse of cost-effectiveness terminology in the gastroenterology literature: a systematic review 2002 ·The American Journal of Gastroenterology ·John K. Marshall, (unknown), Deborah Yamamura, Subhas C. Ganguli, (unknown), Bernie J. OʼBrien	6
12	Cross-Chimeric Analysis of Selectivity of Secretin and VPAC1 Receptor Activation 2000 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), Subhas C. Ganguli, Delia I. Pinon, Elizabeth M. Hadac, Laurence J. Miller	19
13	Structural Insights into the Amino-Terminus of the Secretin Receptor: I. Status of Cysteine and Cystine Residues 2000 ·Molecular Pharmacology ·Yan W. Asmann, Maoqing Dong, Subhas C. Ganguli, Elizabeth M. Hadac, Laurence J. Miller	36
14	Structural Insights into the Amino-Terminus of the Secretin Receptor: I. Status of Cysteine and Cystine Residues 2000 ·Molecular Pharmacology ·Yan W. Asmann, Maoqing Dong, Subhas C. Ganguli, Elizabeth M. Hadac, Laurence J. Miller	4
15	Budd-chiari syndrome in patients with hematological disease: A therapeutic challenge 1998 ·Hepatology ·Subhas C. Ganguli, Nizar N. Ramzan, (unknown), James C. Andrews, Robert L. Phyliky, Patrick S. Kamath	29
16	Protean Effects of a Natural Peptide Agonist of the G Protein-Coupled Secretin Receptor Demonstrated by Receptor Mutagenesis 1998 ·Journal of Pharmacology and Experimental Therapeutics ·Subhas C. Ganguli, (unknown), Martin Holtmann, Elizabeth M. Hadac, Terry Kenakin, Laurence J. Miller	62
17	Focused cross-chimeric analysis of secretin/VIP ligand-receptor interactions 1998 ·Gastroenterology ·(unknown), Subhas C. Ganguli, Delia I. Pinon, L. J. Miller	1
18	Multiple Extracellular Loop Domains Contribute Critical Determinants for Agonist Binding and Activation of the Secretin Receptor 1996 ·Journal of Biological Chemistry ·Martin Holtmann, Subhas C. Ganguli, Elizabeth M. Hadac, (unknown), Laurence J. Miller	89

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact